Prayer in Commbate to Corona Virus - Covid -19

March 16, 2022 updated by: Hospital do Coracao

A Double Blind, Controlled, Randomized, Prospective Study That Will Evaluate the Impact of Remote Intercession Prayer on the Clinical Evolution of Patients Diagnosed With COVID -19 in HCOR.

PATIENTS WHO ARE ADMITTED TO HOSPITALIZATION IN HCOR AND WHO HAVE THE CONFIRMED DIAGNOSIS OF CORONA VIRUS, WILL BE ASKED TO CONSENT TO PARTICIPATE IN THIS STUDY THAT INTENDS TO STUDY THE EFFECTIVENESS OF THE REMOTE INTERCESSION PRAYER IN COMBATING THIS DISEASE.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

PATIENTS WHO AGREE TO PARTICIPATE IN THE STUDY WILL BE SEPARATED INTO 2 GROUPS, THE INTERVENTION GROUP AND THE CONTROL GROUP.

THE IDENTITY OF THE PATIENTS WILL BE KEPT IN SECRET AND ONLY THEIR INITIALS WILL BE LISTED.

THE INTERVENTION GROUP WILL RECEIVE DAILY PRAYERS AND THE EVOLUTIONARY CLINICAL RESULTS OF THE TWO GROUPS WILL BE PURCHASED.

Study Type

Interventional

Enrollment (Actual)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • SP
      • Sao Paulo, SP, Brazil, 04005-000
        • Hospital do Coracao

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

Patients hospitalized in comun hospital rooms and intensive care units with confirmed COVID-19.

Exclusion Criteria:

  • Patients admitted to the HCor emergency room, diagnosed with COVID-19 infection, however, without indication for hospitalization
  • Patients admitted to the HCor emergency room, diagnosed with COVID-19 infection, however, without indication for hospitalization.
  • Patients 18 years of age or older
  • Patients with indication of palliative care and definition of terminality at hospital admission
  • Patients who voluntarily choose not to participate in the study at the time of the • presentation of the Informed Consent Form.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: CONTROL
THIS GROUP WILL RECEIVE THE PROTCOLL TREATMENT GIVEN TO PATIENTS COVID -POSITIVE TESTED.
Experimental: PRAYER
THIS GROUP WILL RECEIVE THE SAME TREATMENT GIVEN TO THE CONTROL GROUP, PLUS PRAYERS BY THEOLOGIANS WHOSE PRAYERS INTERCEDE IN FAVOR OF THEIR PROMPT RECOVERY
THE PRAYER GROUP WILL RECEIVE ABSOLUTELY THE SAME CARE AS THE CONTROL GROUP PLUS PRAYERS
Other Names:
  • INTERCESSORY PRAYER

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
DEATH OR RECOVERY
Time Frame: 60 DAYS
WE WILL EVALUATE DEATHS OR HOSPITAL DISCHARGE
60 DAYS

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
NEED FOR MECHANICAL VENTILATION
Time Frame: 60 DAYS
NEED FOR MECHANICAL VENTILATION
60 DAYS
TIME OF REMAINED INTUBATED
Time Frame: 60 DAYS
TIME OF REMAINED INTUBATED
60 DAYS
LENGTH OF STAY IN ICU
Time Frame: 60 DAYS
LENGTH OF STAY IN ICU
60 DAYS
TIME OF STAY HOSPITALIZED
Time Frame: 60 DAYS
TIME OF STAY HOSPITALIZED
60 DAYS
Occurrence of clinical complications.
Time Frame: 60 DAYS
Occurrence of clinical complications that were not included before diagnostic confirmation and that may be related to covid infection.
60 DAYS

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: NATHAN V SOUBIHE JR, Hospital do Coracao

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2020

Primary Completion (Actual)

June 1, 2021

Study Completion (Actual)

January 1, 2022

Study Registration Dates

First Submitted

August 4, 2020

First Submitted That Met QC Criteria

November 13, 2020

First Posted (Actual)

November 17, 2020

Study Record Updates

Last Update Posted (Actual)

March 17, 2022

Last Update Submitted That Met QC Criteria

March 16, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • PRAYER-COVID19

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

They will not

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Covid19

Clinical Trials on PRAYER

Subscribe